Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)   3

The purpose of Amendment No. 1 to the APECx RDS is to extend the abstract due date to December 15, 2023 at 9:00 AM ET and to extend the proposal due date to February 16, 2024 at 5:00 PM ET. Additional minor changes to the RDS are highlighted in yellow. A revised RDS is attached to this amendment.

As a reminder, proposals will be invite-only and an abstract must be submitted to be invited to submit a proposal. Please ensure to follow this opportunity for any further updates.

-------------------------------------------------------------------------------------------------------------------------------

The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.

Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 1, 2023, 9:00 AM ET. Proposals will be invite-only and will be due January 19, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal.

Please ensure to follow this opportunity for any updates.

For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.

Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.